FLSM
Frazier Life Sciences Management’s AnaptysBio ANAB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,573,719
| Closed | -$20.8M | – | 48 |
|
|
2024
Q4 | $20.8M | Sell |
1,573,719
-635,470
| -29% | -$8.41M | 0.86% | 25 |
|
|
2024
Q3 | $74M | Buy |
2,209,189
+43,598
| +2% | +$1.46M | 2.97% | 13 |
|
|
2024
Q2 | $54.3M | Buy |
2,165,591
+1,265,891
| +141% | +$31.7M | 2.54% | 12 |
|
|
2024
Q1 | $20.3M | Hold |
899,700
| – | – | 0.85% | 31 |
|
|
2023
Q4 | $19.3M | Hold |
899,700
| – | – | 1.03% | 27 |
|
|
2023
Q3 | $16.2M | Hold |
899,700
| – | – | 1.07% | 22 |
|
|
2023
Q2 | $18.3M | Hold |
899,700
| – | – | 1.09% | 22 |
|
|
2023
Q1 | $19.6M | Hold |
899,700
| – | – | 1.42% | 19 |
|
|
2022
Q4 | $27.9M | Hold |
899,700
| – | – | 1.73% | 14 |
|
|
2022
Q3 | $23M | Hold |
899,700
| – | – | 1.77% | 16 |
|
|
2022
Q2 | $18.3M | Hold |
899,700
| – | – | 1.72% | 16 |
|
|
2022
Q1 | $22.3M | Buy |
+899,700
| New | +$22.3M | 1.9% | 17 |
|